Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark

INTRODUCTION: Programmed cell death ligand-1 (PD-L1) expression may help identify patients with non-small cell lung cancer (NSCLC) who would benefit from immunotherapy. We assessed PD-L1 expression, and epidermal growth factor receptor (EGFR) and V-Ki-Ras2 Kirsten rat sarcoma (KRAS) mutations in NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalvi, Tapashi, Nørgaard, Mette, Fryzek, Jon P., Movva, Naimisha, Pedersen, Lars, Pham Hansen, Hanh, Walker, Jill, Midha, Anita, Shire, Norah, Boothman, Anne-Marie, Rigas, James, Mellemgaard, Anders, Rasmussen, Torben R., Hamilton-Dutoit, Stephen, Cronin-Fenton, Deirdre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089313/
https://www.ncbi.nlm.nih.gov/pubmed/37040387
http://dx.doi.org/10.1371/journal.pone.0284037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089313/
https://www.ncbi.nlm.nih.gov/pubmed/37040387
http://dx.doi.org/10.1371/journal.pone.0284037

Ejemplares similares